Invention Application
- Patent Title: METHODS OF TREATING CD20 EXPRESSING B-CELL CANCERS
-
Application No.: US18664772Application Date: 2024-05-15
-
Publication No.: US20240409656A1Publication Date: 2024-12-12
- Inventor: Nurgul KILAVUZ , Mariana SACCHI
- Applicant: GENMAB A/S
- Applicant Address: DK Valby
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Valby
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00
Abstract:
The present invention relates to improved methods for reducing cytokine release syndrome following interruption of the epcoritamab dosing schedule for the treatment of CD20 B-cell expressing cancers.
Information query
